LOGIN JOIN SHARECAFE SIGN UP FOR OUR NEWSLETTER ADVERTISE
share cafe logo  
 
SEARCH RESULT

RESMED INC ( RMD )

Discuss RMD In The ShareScene Community


CLICK HERE TO TALK WITH OTHER INVESTORS ABOUT RMD +

RMD Commentary, Multimedia & ASX Announcements


RMD - Morgans rates the stock as Add8/6/2018 10:44:04 AM
RMD - Macquarie rates as Underperform6/29/2018 10:12:16 AM
RMD - Morgan Stanley rates as Overweight4/30/2018 9:00:01 AM
How Much Upside Is There For ResMed?1/24/2018 3:26:22 PM
RMD - UBS rates the stock as Buy1/24/2018 10:38:39 AM
RMD - Morgan Stanley rates the stock as Overweight1/18/2018 10:30:16 AM
How The Market Misinterpreted Resmed's Results8/9/2017 10:46:13 AM
RMD - UBS rates the stock as Buy8/3/2017 11:05:05 AM
A Valuable Treatment6/23/2017 4:49:00 PM
Companies Benefiting From Demographic Trends6/9/2017 10:54:02 AM
Resmed's AirFit Masks Appear To Be Boosting Share3/21/2017 10:33:13 AM
Resmed's Growing Customer Base2/6/2017 12:23:46 PM
Resmed Upbeat On Stronger Q2 Sales1/25/2017 8:31:54 AM
RMD - Morgans rates the stock as Overweight1/19/2017 11:51:30 AM
RMD - Citi rates the stock as Buy12/9/2016 11:22:05 AM
RMD - Credit Suisse rates the stock as Outperform10/27/2016 10:24:29 AM
RMD - UBS rates the stock as Buy9/8/2016 10:55:21 AM
Resmed Produces Another Solid Result8/5/2016 11:56:34 AM
RMD - UBS rates the stock as Buy8/2/2016 10:42:25 AM
RMD - Credit Suisse rates the stock as Outperform8/1/2016 12:44:03 PM
RMD - Credit Suisse rates the stock as Outperform4/28/2016 10:52:55 AM
RMD - Credit Suisse rates the stock as Outperform3/17/2016 10:46:19 AM
RMD - Citi rates the stock as Neutral1/25/2016 10:32:18 AM
RMD - Citi rates the stock as Neutral1/18/2016 11:01:43 AM
ResMed Faces Challenges In FY1610/26/2015 4:24:43 PM
RMD - UBS rates the stock as Buy10/26/2015 10:50:16 AM
To The Victor10/15/2015 2:14:02 PM
More Impediments To ResMed's ASV Program9/7/2015 3:15:34 PM
RMD - Citi rates the stock as Neutral9/7/2015 11:12:41 AM
RMD - Macquarie rates the stock as Underperform7/14/2015 12:35:39 PM
Losing Heart5/18/2015 2:33:08 PM
RMD - Macquarie rates the stock as Neutral5/15/2015 12:29:37 PM
Resmed Pounded On Trial Failure5/15/2015 8:21:23 AM
RMD - UBS rates the stock as Buy5/14/2015 12:29:34 PM
RMD - Deutsche Bank rates the stock as Hold4/27/2015 12:13:43 PM
RMD - CS rates the stock as Outperform4/10/2015 12:12:00 PM
RMD - UBS rates the stock as Buy10/8/2014 1:12:23 PM
RMD - Citi rates the stock as Buy, Medium Risk9/30/2014 11:31:31 AM
RMD - Citi rates the stock as Buy, Medium Risk 9/3/2014 12:25:41 PM
Making Sense Of ResMed's New Platform8/22/2014 12:40:32 PM
RMD - BA-Merrill Lynch rates the stock as Buy7/4/2014 11:31:23 AM
Brokers Warm To ResMed As Price Disruptions Abate4/28/2014 4:12:28 PM
Checking In On ResMed3/17/2014 12:15:04 PM
ResMed In A Holding Pattern1/31/2014 11:05:49 AM
Is Resmed A Stock Pick?11/7/2013 10:49:00 AM
Time for ResSleep?9/20/2013 9:50:25 AM
Video - Is This Our Top Five?9/17/2013 12:43:01 PM
Brokers Breathe Easier Over ResMed8/7/2013 10:07:14 AM
RMD - Macquarie rates the stock as Outperform8/6/2013 9:51:13 AM
RMD - Macquarie rates the stock as Outperform7/17/2013 10:20:11 AM

There Is No Multimedia Available For This Company.

ResMed to Announce Second Quarter Fiscal Year 2018 Results 1/4/2018 10:16:00 AM
ResMed to Announce Third Quarter Fiscal Year 2017 Results 3/31/2017 9:40:00 AM
Update - Dividend/Distribution - RMD 2/13/2017 12:37:00 PM
Update - Dividend/Distribution - RMD 2/10/2017 11:36:00 AM
Appendix 3B 1/25/2017 5:25:00 PM
ResMed Announces Results for the Second Qtr of FY 2017 1/25/2017 5:23:00 PM
Dividend/Distribution - RMD 1/24/2017 9:46:00 AM
ResMed Announces Results for the Second Qtr of FY 2017 1/24/2017 8:51:00 AM
Amended Form 10 K and Annual Report 1/16/2017 10:03:00 AM
Form 8-K 1/13/2017 9:55:00 AM
ResMed to Announce Second Quarter Fiscal Year 2017 Results 12/20/2016 9:47:00 AM
FPH: Successful in German Court Proceedings 12/2/2016 7:36:00 AM
8-K Annual Meeting Stockholders - Results 11/21/2016 10:22:00 AM
Update - Dividend/Distribution - RMD 11/11/2016 12:26:00 PM
Official notification of AGM (Proxy) 10/31/2016 3:02:00 PM
Amended Additional Proxy Soliciting Materials 10/31/2016 3:02:00 PM
Additional Proxy Soliciting Materials 10/31/2016 2:51:00 PM
Appendix 3B 10/31/2016 9:37:00 AM
Form 10Q for QTR ended September 3010/31/2016 9:34:00 AM
Dividend/Distribution - RMD 10/27/2016 4:46:00 PM
ResMed Announces Results for the First Qtr of FY 2017 10/26/2016 9:08:00 AM
ResMed to Announce First Quarter Fiscal Year 2017 Results 9/28/2016 8:58:00 AM
Update - Dividend/Distribution - RMD 9/13/2016 3:10:00 PM
FPH: Updated FPH Contests Patent Infringement Allegations 8/18/2016 8:27:00 AM
FPH: FPH Contests Patent Infringement Allegations 8/18/2016 7:44:00 AM
FPH: FPH FILE PATENT INFRINGEMENT PROCEEDINGS AGAINST RESMED 8/16/2016 8:10:00 AM
Appendix 3B 8/8/2016 9:50:00 AM
Form 10-K & Annual Report For the Year Ended June 308/8/2016 9:50:00 AM
Dividend/Distribution - RMD 7/29/2016 12:18:00 PM
Financial Results for the Fourth Quarter & Fiscal Year 2016 7/29/2016 9:42:00 AM
ResMed to Announce Fourth Quarter Fiscal Year 2016 Results 7/8/2016 9:29:00 AM
Form 8K/A 6/10/2016 9:57:00 AM
ResMed FORM SD 6/1/2016 9:25:00 AM
Update - Dividend/Distribution - RMD 5/20/2016 1:23:00 PM
Appendix 3B 5/2/2016 10:05:00 AM
Form 10Q for QTR ended March 315/2/2016 9:39:00 AM
Dividend/Distribution - RMD 4/27/2016 10:00:00 AM
ResMed Announces Results for the Third Qtr of FY 2016 4/27/2016 9:18:00 AM
Exhibits relating to Form 8-K 4/5/2016 10:23:00 AM
FORM 8-K 4/5/2016 9:55:00 AM
ResMed to Announce 3rd Qtr Fiscal Year 2016 results 3/29/2016 10:11:00 AM
RNO: Termination of relationship 3/24/2016 4:54:00 PM
Form 8-K Material Agreement 2/23/2016 10:14:00 AM
ResMed to Acquire Brightree 2/23/2016 9:05:00 AM
Update - Dividend/Distribution - RMD 2/12/2016 12:05:00 PM

 

SHARECAFE VIDEO


Key movements in the Australian ETF market

More video   

RECENTLY ADDED TO SHARECAFE


 › Domino's Fails To Deliver
 › Investors Deaf To Cochlear Growth Story
 › July China Data Disappoints
 › Business Conditions Wane In July
 › Wednesday At The Open
 › Marcus Today End Of Day Report
 › Tuesday At The Close
 › The Global Economy & Bond Markets According To Franklin Templeton
 › Compliance Costs Bite As NAB Provides Mixed Q3 Update
 › Whitehaven Doubles Down With Second Special Dividend
 › Market At Midday On Tuesday
 › Overnight: Mild Concern
 › COE - Morgans rates as Add
 › AZJ - Morgan Stanley rates as Underweight
More ShareCafe   

GET THE SHARECAFE BREAKFAST BRIEFING


Delivered free to your inbox before the market opens each trading day. Sign up below +